Cozad Asset Management Inc Edwards Lifesciences Corp Transaction History

Cozad Asset Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$72.54 - $95.56 $189,764 - $249,984	2,616 New	2,616 $249,000
Q1 2023 May 01, 2023	BUY	$74.26 - $84.51 $194,264 - $221,078	2,616 New	2,616 $216,000
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $24,711 - $32,187	-300 Reduced 10.29%	2,616 $216,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $37,627 - $55,797	-435 Reduced 12.98%	2,916 $277,000
Q1 2022 Apr 29, 2022	SELL	$101.96 - $128.34 $318,319 - $400,677	-3,122 Reduced 48.23%	3,351 $394,000
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $109,986 - $135,123	-1,034 Reduced 13.77%	6,473 $839,000
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $1.05 Million - $1.26 Million	-10,239 Reduced 57.7%	7,507 $850,000
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $1.38 Million - $1.73 Million	-16,495 Reduced 48.17%	17,746 $1.84 Million
Q1 2021 Apr 29, 2021	SELL	$78.68 - $90.67 $786 - $906	-10 Reduced 0.03%	34,241 $2.86 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $67,388 - $85,756	-940 Reduced 2.67%	34,251 $3.13 Million
Q3 2020 Oct 28, 2020	SELL	$67.19 - $87.44 $202,577 - $263,631	-3,015 Reduced 7.89%	35,191 $2.81 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.41 Million - $1.89 Million	24,569 Added 180.16%	38,206 $2.64 Million
Q1 2020 May 07, 2020	BUY	$52.41 - $81.0 $34,957 - $54,027	667 Added 5.14%	13,637 $2.57 Million
Q4 2019 Jan 16, 2020	BUY	$71.7 - $82.09 $168,495 - $192,911	2,350 Added 22.13%	12,970 $3.03 Million
Q3 2019 Oct 31, 2019	BUY	$61.55 - $75.43 $653,661 - $801,066	10,620 New	10,620 $2.34 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cozad Asset Management Inc with notifications on news.